Abstract
Pregnant rats were treated during organogenesis with s.c. injections of acyclovir and the embryos were evaluated on day 11.5 of gestation (crown-rump length, somites, protein content, score, abnormalities, histological examination). After eight injections of 50 mg/kg body wt on days 9, 10, and 11 of pregnancy a reduction of the crownrump length was noticed. After 100 mg/kg this effect was more pronounced. With two or three applications of this dose on day 10 specific embryonic abnormalities were visible: the shape of the head was abnormal, the width of the skull had decreased resembling a beak-like visceral cranium. With a single administration of 200 mg/kg on day 10 we found a similar but slightly more pronounced outcome. A drastic change of all variables was obtained after eight injections of 100 mg/kg on days 9, 10, and 11. Comparatively we measured maternal plasma concentrations of acyclovir 1 h after the administration of 50, 100 or 200 mg/kg body wt. After an injection of 50 mg/kg on days 9, 10, and 11 of gestation (three injections/day) the plasma levels ranged from 19.1 to 40.0 mg/l (1 mg/l = 4.44 μM). No cumulation was observed. In contrast, a cumulative effect was detected following a dose of 100 mg/kg. After the first injection of this dose a mean value (± SD) of 60.3±14.7 mg/l (n = 16) was obtained. In this case a third injection increased the mean plasma level to 124.6±16.6 mg/l (n = 5). Further injections, however, led to decreasing levels. One hour after administration of 200 mg/kg body wt acyclovir levels ranged from 120.0 to 163.9 mg/l. We conclude that acyclovir, at doses leading to plasma concentrations well above the therapeutic level in the dam, interferes with the embryonic development in the rat. Acyclovir induces typical gross structural abnormalities which have been first observed using a whole embryo culture system.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andersson J, Britton S, Ernberg I, Andersson U, Henle W, Sköldenberg B, Tisell A (1986) Effect of acyclovir on infectious mononucleosis: A double-blind, placebo-controlled study. J Infect Dis 153: 283–290
Bochert G, Rahm U, Schwabe R, Meister R (1987) Plasma concentrations of acyclovir in pregnant rats. Naunyn-Schmiedeberg's Arch Pharmacol 335 (Suppl): R29 (Abstr. No. 116)
De Miranda P, Krasny HC, Page DA, Elion GB (1981) The disposition of acyclovir in different species. J Pharmacol Exp Ther 219: 309–315
Elion GB (1982) Mechanism of action and selectivity of acyclovir. Am J Med 73 (Suppl): 7
Furuhama K, Onodera T (1983) A simple technique for repeated blood collection from the tail vein of the rat. Toxicol Sci 8: 161–163
Hayden FG, Douglas RG Jr (1985) Antiviral agents. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice of infectious diseases, 2nd Edition, John Wiley & Sons, New York Chichester Brisbane, pp 270–286
Heinrich-Hirsch B, Jacob-Müller U (1987) Studies on the embryotoxic effect of acyclovir on the development of chick embryos. Naunyn-Schmiedeberg's Arch Pharmacol 335 (Suppl): R29 (Abstr. No. 115)
Klug S, Lewandowski C, Blankenburg G, Merker H-J, Neubert D (1985a) Effect of acyclovir on mammalian embryonic development in culture. Arch Toxicol 58: 89–96
Klug S, Lewandowski C, Neubert D (1985b) Modification and standardization of the culture of early postimplantation embryos for toxicological studies. Arch Toxicol 58: 84–88
Moore HL Jr, Szczech GM, Rodwell DE, Kapp RW Jr, De Miranda P, Tucker WE Jr (1983) Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests. Fund Appl Toxicol 3: 560–568
Neubert D, Blankenburg G, Chahoud I, Franz G, Herken R, Kastner M, Klug S, Kröger J, Krowke R, Lewandowski C, Merker H-J, Schulz T, Stahlmann R (1986) Results of in vivo and in vitro studies for assessing prenatal toxicity. Environ Health Perspectives 70: 89–103
Shepp DH, Dandliker PS, Meyers JD (1986) Treatment of varicella-zoster virus infection in severely immunocompromised patients. N Engl J Med 314: 208–212
Smith RL, Walker DD (1985) High-performance liquid chromatographic determination of acyclovir in serum. J Chromatogr 343: 203–207
Stahlmann R, Chahoud I (1987) Teratogenic potential of acyclovir in rats. Naunyn-Schmiedeberg's Arch Pharmacol 335 (Suppl): R29 (Abstr. No. 114)
Tucker WE Jr, Clive D (1983) Preclinical toxicology profile of acyclovir: an overview. Poster representation at 2nd International Acyclovir (Zovirax) Symposium, London 1983
Tucker WE Jr, Macklin AW, Szot RJ, Johnston RE, Elion GB, De Miranda P, Szczech GM (1983) Preclinical toxicology studies with acyclovir: Acute and subchronic tests. Fund Appl Toxicol 3: 573–578
Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong S-J (1986) NIAID Collaborative Antiviral Study Group, 1986, Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314: 144–149
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stahlmann, R., Klug, S., Lewandowski, C. et al. Prenatal toxicity of acyclovir in rats. Arch Toxicol 61, 468–479 (1988). https://doi.org/10.1007/BF00293693
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00293693